PODD News Alert Insulet Corp (PODD) 42.48 12/17/2014 03:15:2

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Insulet Corp (PODD) 42.48 $PODD

Global Continuous Glucose Monitoring System 2014 - 2020
M2 - Fri Dec 12, 2:56AM CST
Research and Markets (http://www.researchandmarkets.com/research/ccxjt3/global_continuous) has announced the addition of the "Global Continuous Glucose Monitoring System 2014 - 2020" report to their offering. Emergence of continuous glucose monitoring systems is a major breakthrough in the glucose monitoring for diabetic patients. Medtronic and Dexcom are the only major players in this industry followed by Abbott in few regions. Companies are focusing more on research and development before introducing their products in the market. CGMS are highly regulated and go through strict tests before being approved. CGM manufacturers have faced competition from Finger based self-monitoring blood glucose devices. SMBG devices are cheaper and easy to use and are easily approved by the authorities. SMBG has more number of players and larger market share. However, CGM systems have been able to make a good market entry in the U.S. and are following the trend in other territories. . CGM system market has seen good growth rates in past three years. Medtronic and Dexcom have introduced new systems which have witnessed lower frequency of errors. The MARD value for new sensors has decreased, new devices need lesser calibrations per day and most of the devices are approved for pediatric use. This has led to 50-60 percent jump in the revenues of some manufacturers. Global Continuous Glucose Monitoring System Market - CGM Market - Real Time Monitoring - Integrated Insulin Pumps - Blood Glucose - Manufacturers - Global Health - IPRO Glucose - MARD - SMBG - Growing Diabetic Population - Type 1 & 2 Diabetes - Nocturnal Hypoglycemia Key Topics Covered: Chapter 1. Executive Summary Chapter 2. Market Overview Chapter 3. Market Determinants Chapter 4. Sector Analysis: Diabetes Care Chapter 5. Cgms Market By Devices Chapter 6. By Application Chapter 7. Competitive Intelligence Chapter 8. Market Share Analysis Chapter 9. Geographical Analysis Chapter 10. Corporate Profile: Benchmark Study - Medtronic Inc. - Dexcom - Abbott - Johnson And Johnson (J&J) (Animas Corp) - Insulet Corp - Tandem Diabetes - Echo Therapeutics For more information visit http://www.researchandmarkets.com/research/cc...continuous
ECTE: 1.12 (-0.12), JNJ: 102.76 (-1.20), PODD: 42.48 (+0.30), MDT: 71.34 (-0.65)

Insulet Up 23.2% Since SmarTrend Uptrend Call (PODD)
Comtex SmarTrend(R) - Mon Dec 08, 9:49AM CST
SmarTrend identified an Uptrend for Insulet (NASDAQ ODD) on September 24th, 2014 at $37.83. In approximately 3 months, Insulet has returned 23.16% as of today's recent price of $46.59.
PODD: 42.48 (+0.30)

DexCom CEO Terry Gregg Explains 50% YTD Stock Leap, Plans for 2015
at The Street - Wed Dec 03, 3:54PM CST
DexCom shares are up over 50% for the year on four FDA approvals. CEO Terry Gregg says technology is driving its products to the forefront.
JNJ: 102.76 (-1.20), ABT: 43.40 (-0.06), PODD: 42.48 (+0.30), DXCM: 53.26 (+0.41), TNDM: 11.29 (+0.09), AAPL: 106.75 (-1.47)

Next-Generation OmniPod Pumping Up Profitability At Insulet Corp.
Cory Renauer - Seeking Alpha - Wed Dec 03, 1:26PM CST
I'm beginning coverage of Insulet Corporation (NASDAQ: PODD ) with a somewhat buy recommendation. The long case is largely based on rapid revenue growth, expanding margins, and a potential takeover. When recently appointed CEO Patrick Sullivan took...
PODD: 42.48 (+0.30)

Insulet Has Returned 19.7% Since SmarTrend Recommendation (PODD)
Comtex SmarTrend(R) - Mon Dec 01, 9:23AM CST
SmarTrend identified an Uptrend for Insulet (NASDAQ ODD) on September 24th, 2014 at $37.83. In approximately 2 months, Insulet has returned 19.67% as of today's recent price of $45.27.
PODD: 42.48 (+0.30)

Insulet Corporation to Present at Upcoming Investor Conferences
Marketwired - Mon Nov 24, 3:15PM CST
Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod(R) Insulin Management System, plans to participate in the following upcoming investor conferences:
PODD: 42.48 (+0.30)

Insulet Earnings Review: 19 Days after Announcement Shares Up 12.4% (PODD)
Comtex SmarTrend(R) - Mon Nov 24, 8:45AM CST
Two weeks ago on November 5th, 2014 Insulet (NASDAQ ODD) reported earnings and analysts, on average, expected a loss of $0.01 on sales of $75.3 million. Insulet actually reported a loss of $0.19 per share on sales of $75.0 million, missing EPS estimates by $0.18 and matching revenue estimates. Shares of Insulet have climbed from $40.27 to $45.26, representing a gain of 12.4% since the company reported earnings 19 days ago.
PODD: 42.48 (+0.30)

Insulet Up 19.6% Since SmarTrend Uptrend Call (PODD)
Comtex SmarTrend(R) - Fri Nov 21, 4:52PM CST
SmarTrend identified an Uptrend for Insulet (NASDAQ ODD) on September 24th, 2014 at $37.83. In approximately 2 months, Insulet has returned 19.64% as of today's recent price of $45.26.
PODD: 42.48 (+0.30)

Post Earnings Update: Insulet Has Climbed 12.2% Higher in Past Week (PODD)
Comtex SmarTrend(R) - Mon Nov 17, 2:58PM CST
12 days ago, on November 5th, 2014, Insulet (NASDAQ ODD) reported its earnings. Analysts, on average, expected a loss of $0.01 per share on sales of $75.3 million. The company actually reported a loss of $0.19 per share on sales of $75.0 million, missing EPS estimates by $0.18 and matching revenue estimates. Since the company's report, shares of Insulet have risen from $40.27 to $45.17, representing a gain of 12.2% in the past 12 days.
PODD: 42.48 (+0.30)

Uptrend Call Working As Insulet Stock Rises 20.9% (PODD)
Comtex SmarTrend(R) - Fri Nov 14, 11:12AM CST
SmarTrend identified an Uptrend for Insulet (NASDAQ ODD) on September 24th, 2014 at $37.83. In approximately 2 months, Insulet has returned 20.86% as of today's recent price of $45.72.
PODD: 42.48 (+0.30)

Global Insulin Delivery Devices Market Outlook 2018
M2 - Thu Nov 13, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/ttg7ws/global_insulin) has announced the addition of the "Global Insulin Delivery Devices Market Outlook 2018" report to their offering. In 2013, a total of 382 Million People had diabetes and by 2030 this number is expected to rise to 552 Million. This finding by the International Diabetes Federation (IDF) and similar results from studies done by organizations of repute such as WHO, CDC, NHS, etc., suggest that a huge patient population exists in the diabetes market. In 2013, health expenditure on diabetes accounted for around 10% of the total health expenditure globally. Of all the market segments that result from this multibillion dollar expenditure, insulin delivery devices represents one of the most rapidly expanding areas and is thus the key focus of this current study. In this latest research study Global Insulin Delivery Devices Market Outlook 2018, the analysts identified the market dynamics in various important regions to highlight the areas offering promising opportunities to companies for boosting their growth. Insulin delivery devices predominantly include Insulin Syringes, Insulin Pens (Disposable and Reusable), Insulin Pumps and Insulin Jet Injectors. Our study provides a comprehensive analysis of the delivery devices market, both at global and regional levels. This analysis includes the current market statistics, key drivers stimulating each segment's growth, and the future outlook of the segments. Key Topics Covered: 1. Analyst View 2. Research Methodology 3. Global Insulin Market Overview to 2018 4. Industry Trends and Drivers 5. Key Market Restraints 6. Global Insulin Delivery Devices Market Outlook to 2018 7. Insulin Delivery Devices: Current and Future Outlook to 2018 8. Emerging Devices 9. Key Players Companies Mentioned: - Abbott Laboratories - B. Braun Melsungen AG - Becton Dickinson - Eli Lilly - F. Hoffmann La Roche - Insulet Corporation - Johnson and Johnson - Medtronic - Novo Nordisk - Sanofi-Aventis - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/tt...al_insulin
JNJ: 102.76 (-1.20), ABT: 43.40 (-0.06), PODD: 42.48 (+0.30), NVO: 43.29 (-0.35), MDT: 71.34 (-0.65), LLY: 69.26 (-0.41)

Insulet's (PODD) CEO Patrick Sullivan on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 9:41PM CST

PODD: 42.48 (+0.30)

Insulet tops 3Q profit forecasts
Automated Insights - Wed Nov 05, 4:27PM CST
BEDFORD, Mass. (AP) _ Insulet Corp. (PODD) on Wednesday reported a loss of $10.8 million in its third quarter.
PODD: 42.48 (+0.30)

Insulet misses by $0.18, misses on revenue
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 4:13PM CST

PODD: 42.48 (+0.30)

Insulet (PODD) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Nov 05, 3:25PM CST

PODD: 42.48 (+0.30)

Insulet Corporation Appoints New Chief Financial Officer and Executive Vice President, Human Resources
Marketwired - Wed Nov 05, 3:08PM CST
Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod(R) Insulin Management System, today announced the promotion of Allison Dorval to Chief Financial Officer effective November 6, 2014 and Brad Thomas as Executive Vice President, Human Resources and Organizational Development, effective immediately.
PODD: 42.48 (+0.30)

Insulet Reports Third Quarter 2014 Results
Marketwired - Wed Nov 05, 3:08PM CST
Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod(R) Insulin Management System, today announced financial results for the three and nine months ended September 30, 2014.
PODD: 42.48 (+0.30)

Insulet Shares Up 14.4% Since SmarTrend's Buy Recommendation (PODD)
Comtex SmarTrend(R) - Fri Oct 31, 9:34AM CDT
SmarTrend identified an Uptrend for Insulet (NASDAQ ODD) on September 24th, 2014 at $37.83. In approximately 1 month, Insulet has returned 14.43% as of today's recent price of $43.29.
PODD: 42.48 (+0.30)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

QuidelOrtho Faces Fresh Scrutiny Over Savanna Claims

Updated Category News Views 172

A diagnostic launch can turn into a corporate migraine with frightening speed, and QuidelOrtho is staring at exactly that sort of mess. Kahn Swick & Foti said on November 20, 2026, that it has begun investigating whether QuidelOrtho officers or directors breached fiduciary duties or otherwise violated state or federal law. This is not a finding of wrongdoing. It is an...

Continue Reading
California Rideshare Data Exposes an Insurance Gap

Updated Category News Views 52

Three California counties carried an outsized share of rideshare traffic, and the insurance fine print is where this story gets uncomfortable. A review by Mendez & Sanchez says Los Angeles, San Francisco, and San Diego counties accounted for nearly two-thirds of statewide rideshare trips between September 2019 and August 2020. That is an old snapshot, sure, but it points...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 134

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 211

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 154

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 71

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 118

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Lyft Upgraded to Buy: Insights for Future Growth Potential

Updated Category News Views 292

Lyft's Upgrade by Benchmark: A Closer Look Benchmark analysts have recently upgraded Lyft (NASDAQ: LYFT) from Hold to Buy, highlighting what's described as "significant optionality" for the rideshare company. This decision comes despite the heightened competition from major players like Tesla and Waymo, indicating confidence in Lyft's capability to navigate potential...

Continue Reading
LiveOne Board Changes Amid Expansion and Financial Growth

Updated Category News Views 120

LiveOne Announces Departure of Board Member LiveOne, Inc. (NASDAQ:LVO) has recently made headlines in the retail-eating sector with the announcement of Craig Foster's resignation from its board of directors. Foster, who also contributed to the Audit Committee and Nominating and Corporate Governance Committee, stepped down to focus on his other professional commitments....

Continue Reading
Concorde International Group's Remarkable 80% After-Hours Surge

Updated Category News Views 429

Concorde International Group's Stock Surge Explained Concorde International Group Ltd. (NASDAQ: CIGL) has captured attention in the stock market after experiencing an impressive 80.16% increase during after-hours trading, reaching a price of $4.63. Investors are buzzing and speculating about what led to this dramatic leap. Exciting New Equity Incentive Plan Announced The...

Continue Reading
Celebrating the Legacy of Dr. Iain Douglas-Hamilton

Updated Category News Views 301

Special Screenings of A Life Among Elephants In a remarkable celebration of conservation, special screenings of the inspiring film A Life Among Elephants will honor the legacy of Dr. Iain Douglas-Hamilton. This film encapsulates the essence of his lifelong dedication to elephant conservation, portraying not only the threats faced by these majestic creatures but also the...

Continue Reading
Saudi Arabia Launches Major SME Report at Biban24 Event

Updated Category News Views 75

Saudi Arabia Presents Key Economic Insights at Biban24 As Saudi Arabia continues its path toward achieving ambitious Vision 2030 objectives, Monsha'at, the authority dedicated to small and medium enterprises (SMEs), is hosting Biban24. This significant event, designed to promote entrepreneurship and growth opportunities, brings together global entrepreneurs and investors...

Continue Reading